Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(26)
- Computing and Computational Sciences Directorate (38)
- Energy Science and Technology Directorate (223)
- Fusion and Fission Energy and Science Directorate (24)
- Information Technology Services Directorate (3)
- Isotope Science and Enrichment Directorate (7)
- National Security Sciences Directorate (20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (135)
- User Facilities (27)
Researcher
- Srikanth Yoginath
- James J Nutaro
- Pratishtha Shukla
- Sudip Seal
- Vlastimil Kunc
- Ahmed Hassen
- Ali Passian
- Brian Sanders
- Dan Coughlin
- Gerald Tuskan
- Harper Jordan
- Ilenne Del Valle Kessra
- Isaiah Dishner
- Jeff Foster
- Jerry Parks
- Jim Tobin
- Joel Asiamah
- Joel Dawson
- John F Cahill
- Josh Crabtree
- Josh Michener
- Kim Sitzlar
- Liangyu Qian
- Merlin Theodore
- Nance Ericson
- Pablo Moriano Salazar
- Paul Abraham
- Steven Guzorek
- Subhabrata Saha
- Varisara Tansakul
- Vilmos Kertesz
- Vipin Kumar
- Xiaohan Yang
- Yang Liu

Enzymes for synthesis of sequenced oligoamide triads and tetrads that can be polymerized into sequenced copolyamides.
Contact
To learn more about this technology, email partnerships@ornl.gov or call 865-574-1051.

Digital twins (DTs) have emerged as essential tools for monitoring, predicting, and optimizing physical systems by using real-time data.

Simulation cloning is a technique in which dynamically cloned simulations’ state spaces differ from their parent simulation due to intervening events.

Detection of gene expression in plants is critical for understanding the molecular basis of plant physiology and plant responses to drought, stress, climate change, microbes, insects and other factors.

Through the use of splicing methods, joining two different fiber types in the tow stage of the process enables great benefits to the strength of the material change.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).